Trials / Completed
CompletedNCT01934582
A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
A Pharmacokinetic Substudy of Subjects Transitioning From Twice Daily to Three Times Daily Dosing of UT-15C SR (Treprostinil Diethanolamine) in the TDE-PH-304 Protocol
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- United Therapeutics · Industry
- Sex
- All
- Age
- 12 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A sub-study to the TDE-PH-304 protocol to assess the pharmacokinetics of patients transitioning from a twice daily dosing regimen of oral treprostinil to a three times daily dosing regimen.
Detailed description
As noted above in "Brief Summary".
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UT-15C SR | |
| DRUG | treprostinil diethanolamine | Open label study drug. |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2013-09-04
- Last updated
- 2024-01-03
- Results posted
- 2016-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01934582. Inclusion in this directory is not an endorsement.